Biotech Acquisition Company (BIOTU): Price and Financial Metrics
BIOTU Price/Volume Stats
|Current price||$10.14||52-week high||$11.11|
|Prev. close||$10.98||52-week low||$8.73|
|Day high||$10.17||Avg. volume||4,444|
|50-day MA||$9.93||Dividend yield||N/A|
|200-day MA||$10.01||Market Cap||N/A|
BIOTU Stock Price Chart Interactive Chart >
Biotech Acquisition Company (BIOTU) Company Bio
Biotech Acquisition Company operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
BIOTU Latest News Stream
|Loading, please wait...|
BIOTU Latest Social Stream
View Full BIOTU Social Stream
Latest BIOTU News From Around the Web
Below are the latest news stories about Biotech Acquisition Co that investors may wish to consider to help them evaluate BIOTU as an investment opportunity.
New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) announced today that it has closed its initial public offering of 23,000,000 units, including 3,000,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000. The Company’s units are listed on the Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “BIOTU” on January 26, 2021. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Upon sep...
New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. Although the Company may pursue a business target in any industry or geographic location, the Company intends to focus its search for a target business in the healthcare sector. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “BIOTU” beginning January 26, 2021. Each unit consists of one Class A ordinary share and one-half of o...
BIOTU Price Returns